Lupus patients: New study shows that antiphospholipid antibodies can complicate health

A recen6 ss wolf's eye-smt study conducted in Hungary has found that Lupus patients who also have antiphospholipid syndrome (APS)—or who are positive for aPL antibodies even without an APS diagnosis—face added health risks unrelated to blood clots.

APS increases the risk of blood clots that can cause miscarriage, deep vein thrombosis (DVT), pulmonary embolism, heart attack, and stroke.

But the Hungarian study found other other health health complications—such as  haemolytic anaemia, thrombocytopenia and endocarditis— occur more frequently in lupus patients who are aPL positive.

In addition, the study found that lupus patients who have full-blown APS are predisposed to more severe SLE manifestations including pleuritis, interstitial lung disease, myocarditis, nephritis, and organic brain syndrome.

The study was conducted at theDepartment of Rheumatology, University of Szeged, Faculty of Medicine, Albert Szent-Györgyi Health Centre, Szeged, Hungary.

The results of the study were announced in the journal Lupus.

Read more about the study here: